Source: International Congress 2018 – Orphan diseases in children
Disease area: Interstitial lung diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Witt (Munich, Germany), B. Szentes (Munich, Germany), A. Bush (London, United Kingdom), S. Cunningham (Edinburgh, United Kingdom), N. Kiper (Ankara, Turkey), J. Lange (Warsaw, Poland), R. Leidl (Munich, Germany), S. Terheggen-Lagro (Amsterdam, Netherlands), N. Schwerk (Hannover, Germany), D. Snijders (Padova, Italy), M. Griese (Munich, Germany), L. Schwarzkopf (Munich, Germany). Medication for childhood interstitial lung diseases differs internationally. 634

Member's Comments

No comment yet.

Related content which might interest you: Management of children with interstitial lung diseases: the difficult issue of acute exacerbations Source: Eur Respir J 2016; 48: 1559-1563 Year: 2016 Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries Source: ERJ Open Res, 8 (1) 00597-2021; 10.1183/23120541.00597-2021 Year: 2022 Current challenges in diagnosing and treating adults with interstitial lung disease Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease Year: 2014 The management of children with interstitial lung disease Source: International Congress 2018 – Difficult paediatric lung disease Year: 2018 PP116 – Associations between pediatric asthma and adult lung diseases Source: ERS Lung Science Conference 2021 Year: 2021 Smoking and interstitial lung diseases Source: Eur Respir Rev 2015; 24: 428-435 Year: 2015 Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001 Assessment of fibrosis in lung biopsies from the European childhood interstitial lung disease (chILD) registry Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases Year: 2020 A national registry for childhood interstitial and diffuse lung diseases in the United States. Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 A comparison of existing questionnaires for identifying the causes of interstitial and rare lung diseases Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 Progressive fibrosing interstitial lung diseases (PF-ILDs): prevalence and characterization in two Italian referral centers Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Report on the registration of interstitial lung diseases in Spain Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003 Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019 Year: 2019 Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan Source: ERJ Open Res, 6 (2) 00184-2019; 10.1183/23120541.00184-2019 Year: 2020 Clinical study of pediatric interstitial lung diseases in China Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 The internet-based network for the management of children with interstitial lung disease Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease Year: 2014 Longitudinal cost of care in individuals with different subtypes of interstitial lung diseases Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 Air travel for patients with interstitial lung diseases Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009